Association Between Progesterone Elevation on the Day of Human Chronic Gonadotropin Trigger and Pregnancy Outcomes After Fresh Embryo Transfer in In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles

Sandro C Esteves, Gautam Khastgir, Jatin Shah, Kshitiz Murdia, Shweta Mittal Gupta, Durga G Rao, Soumyaroop Dash, Kundan Ingale, Milind Patil, Kunji Moideen, Priti Thakor, Pavitra Dewda, Sandro C Esteves, Gautam Khastgir, Jatin Shah, Kshitiz Murdia, Shweta Mittal Gupta, Durga G Rao, Soumyaroop Dash, Kundan Ingale, Milind Patil, Kunji Moideen, Priti Thakor, Pavitra Dewda

Abstract

Progesterone elevation (PE) during the late follicular phase of controlled ovarian stimulation in fresh embryo transfer in vitro fertilization (IVF)/intracytoplasmic sperm injection cycles has been claimed to be associated with decreased pregnancy rates. However, the evidence is not unequivocal, and clinicians still have questions about the clinical validity of measuring P levels during the follicular phase of stimulated cycles. We reviewed the existing literature aimed at answering four relevant clinical questions, namely (i) Is gonadotropin type associated with PE during the follicular phase of stimulated cycles? (ii) Is PE on the day of human chorionic gonadotropin (hCG) associated with negative fresh embryo transfer IVF/intracytoplasmic sperm injection (ICSI) cycles outcomes in all patient subgroups? (iii) Which P thresholds are best to identify patients at risk of implantation failure due to PE in a fresh embryo transfer? and (iv) Should a freeze all policy be adopted in all the cycles with PE on the day of hCG? The existing evidence indicates that late follicular phase progesterone rise in gonadotropin releasing analog cycles is mainly caused by the supraphysiological stimulation of granulosa cells with exogenous follicle-stimulating hormone. Yet, the type of gonadotropin used for stimulation seems to play no significant role on progesterone levels at the end of stimulation. Furthermore, PE is not a universal phenomenon with evidence indicating that its detrimental consequences on pregnancy outcomes do not affect all patient populations equally. Patients with high ovarian response to control ovarian stimulation are more prone to exhibit PE at the late follicular phase. However, in studies showing an overall detrimental effect of PE on pregnancy rates, the adverse effect of PE on endometrial receptivity seems to be offset, at least in part, by the availability of good quality embryo for transfer in women with a high ovarian response. Given the limitations of the currently available assays to measure progesterone at low ranges, caution should be applied to adopt specific cutoff values above which the effect of progesterone rise could be considered detrimental and to recommend "freeze-all" based solely on pre-defined cutoff points.

Keywords: assisted reproductive technology; controlled ovarian stimulation; human chorionic gonadotropin trigger; in vitro fertilization; intracytoplasmic sperm injection; late follicular phase; pregnancy outcomes; progesterone elevation.

References

    1. Spencer TE, Johnson GA, Burghardt RC, Bazer FW. Progesterone and placental hormone actions on the uterus: insights from domestic animals. Biol Reprod (2004) 71(1):2–10.10.1095/biolreprod.103.024133
    1. Gougeon A. Dynamics of human follicular growth: morphologic, dynamic, and functional aspects. Ovary (2004) 2:25–43.10.1016/B978-012444562-8/50003-3
    1. Hoff JD, Quigley ME, Yen SS. Hormonal dynamics at midcycle: a reevaluation. J Clin Endocrinol Metab (1983) 57(4):792–6.10.1210/jcem-57-4-792
    1. Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev (2004) 25(6):947–70.10.1210/er.2003-0030
    1. Seger R, Hanoch T, Rosenberg R, Dantes A, Merz WE, Strauss JF, III, et al. The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis. J Biol Chem (2001) 276(17):13957–64.10.1074/jbc.M006852200
    1. Leao Rde B, Esteves SC. Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech. Clinics (Sao Paulo) (2014) 69(4):279–93.10.6061/clinics/2014(04)10
    1. Czyzyk A, Podfigurna A, Genazzani AR, Meczekalski B. The role of progesterone therapy in early pregnancy: from physiological role to therapeutic utility. Gynecol Endocrinol (2017) 33:421–4.10.1080/09513590.2017.1291615
    1. Lessey BA. Two pathways of progesterone action in the human endometrium: implications for implantation and contraception. Steroids (2003) 68(10):809–15.10.1016/j.steroids.2003.09.004
    1. Blakemore JK, Kofinas JD, McCulloh DH, Grifo J. Serum progesterone trend after day of transfer predicts live birth in fresh IVF cycles. J Assist Reprod Genet (2017) 34(3):339–43.10.1007/s10815-016-0859-1
    1. Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Jenkins J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod (2010) 25(8):2092–100.10.1093/humrep/deq125
    1. Griesinger G, Mannaerts B, Andersen CY, Witjes H, Kolibianakis EM, Gordon K, et al. Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials. Fertil Steril (2013) 100(6):1622–8.e1–3.10.1016/j.fertnstert.2013.08.045
    1. Venetis C, Kolibianakis E, Bosdou J, Tarlatzis B. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update (2013) 19(5):433–57.10.1093/humupd/dmt014
    1. Venetis CA, Kolibianakis EM, Bosdou JK, Lainas GT, Sfontouris IA, Tarlatzis BC, et al. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles. Hum Reprod (2015) 30(3):684–91.10.1093/humrep/deu362
    1. Xu B, Li Z, Zhang H, Jin L, Li Y, Ai J, et al. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles. Fertil Steril (2012) 97(6):1321–7.e1–4.10.1016/j.fertnstert.2012.03.014
    1. Lee VCY, Li RHW, Chai J, Yeung TWY, Yeung WSB, Ho PC, et al. Effect of preovulatory progesterone elevation and duration of progesterone elevation on the pregnancy rate of frozen–thawed embryo transfer in natural cycles. Fertil Steril (2014) 101(5):1288–93.10.1016/j.fertnstert.2014.01.040
    1. Lee VCY, Li RHW, Ng EHY, Yeung WSB, Ho PC. Luteal phase support does not improve the clinical pregnancy rate of natural cycle frozen-thawed embryo transfer: a retrospective analysis. Eur J Obstet Gynecol Reprod Biol (2013) 169(1):50–3.10.1016/j.ejogrb.2013.02.005
    1. Younis JS, Simon A, Laufer N. Endometrial preparation: lessons from oocyte donation. Fertil Steril (1996) 66(6):873–84.10.1016/S0015-0282(16)58677-4
    1. Fanchin R, Righini C, Olivennes F, Ferreira AL, de Ziegler D, Frydman R. Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy. Fertil Steril (1997) 68(5):799–805.10.1016/S0015-0282(97)90655-5
    1. Schoolcraft W, Sinton E, Schlenker T, Huynh D, Hamilton F, Meldrum DR. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril (1991) 55(3):563–6.10.1016/S0015-0282(16)54186-7
    1. Gurbuz AS, Deveer R, Kucuk M, Ozcimen N, Incesu D, Koseoglu S. Is it possible to prevent ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist triggering and modified luteal support in patients with polycystic ovarian morphology? J Clin Med Res (2016) 8(5):396–401.10.14740/jocmr2500w
    1. Cui N, Zhang J, Xu Y, Jiang L, Yang A, Hao G. Premature progesterone rise positively correlates with clinical pregnancy rate in in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) patients with good ovarian response. Horm Metab Res (2017) 49(5):372–9.10.1055/s-0043-104384
    1. Kumar P, Sharma A. Gonadotropin-releasing hormone analogs: understanding advantages and limitations. J Hum Reprod Sci (2014) 7(3):170.10.4103/0974-1208.142476
    1. Roque M, Valle M, Guimarães F, Sampaio M, Geber S. Freeze-all policy: fresh vs. frozen-thawed embryo transfer. Fertil Steril (2015) 103(5):1190–3.10.1016/j.fertnstert.2015.01.045
    1. Labarta E, Martínez-Conejero J, Alamá P, Horcajadas J, Pellicer A, Simón C, et al. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod (2011) 26(7):der126.10.1093/humrep/der126
    1. Andersen AN, Devroey P, Arce J-C. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod (2006) 21(12):3217–27.10.1093/humrep/del284
    1. Andersen CY, Bungum L, Andersen AN, Humaidan P. Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate. Reprod Biomed Online (2011) 23(2):187–95.10.1016/j.rbmo.2011.04.003
    1. Kolibianakis EM, Venetis CA, Bontis J, Tarlatzis BC. Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: a systematic review and meta-analysis. Curr Pharm Biotechnol (2012) 13(3):464–70.10.2174/138920112799361927
    1. Bosch E, Valencia I, Escudero E, Crespo J, Simón C, Remohí J, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril (2003) 80(6):1444–9.10.1016/j.fertnstert.2003.07.002
    1. Papanikolaou EG, Kolibianakis EM, Pozzobon C, Tank P, Tournaye H, Bourgain C, et al. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril (2009) 91(3):949–52.10.1016/j.fertnstert.2006.12.064
    1. Seow K-M, Lin Y-H, Huang L-W, Hsieh B-C, Huang S-C, Chen CY, et al. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles. Gynaecol Endocrinol (2007) 23(6):338–42.10.1080/09513590701403629
    1. Ubaldi F, Albano C, Peukert M, Riethmüller-Winzen H, Camus M, Smitz J, et al. Endocrinology: subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles. Hum Reprod (1996) 11(7):1405–7.10.1093/oxfordjournals.humrep.a019409
    1. Eleno I, Matallin Evangelio P, Gavila N, Alfayate R, Mauri M, Cremades N, et al. Predictive value of plasma progesterone on hCG administration day in the outcome of IVF-ET cycles [Valor predictivo de la concentración plasmática de progesterona el dia de la administración de la hCG en los resultados de ciclos de FIV/ICSI]. Revista Iberoamericana de Fertilidad (2006) 23(4):257–64.
    1. Requena A, Cruz M, Bosch E, Meseguer M, Garcia-Velasco JA. High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study. Reprod Biol Endocrinol (2014) 12:69.10.1186/1477-7827-12-69
    1. Devroey P, Pellicer A, Andersen AN, Arce J-C, Group MiGACwSETT A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer. Fertil Steril (2012) 97(3):561–71.10.1016/j.fertnstert.2011.12.016
    1. Lawrenz B, Beligotti F, Engelmann N, Gates D, Fatemi H. Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles. Hum Reprod (2016) 31(11):2554–60.10.1093/humrep/dew213
    1. Andersen CY, Ezcurra D. Human steroidogenesis: implications for controlled ovarian stimulation with exogenous gonadotropins. Reprod Biol Endocrinol (2014) 12:128.10.1186/1477-7827-12-128
    1. Smyth C, Miro F, Whitelaw P, Howles C, Hillier S. Ovarian thecal/interstitial androgen synthesis is enhanced by a follicle-stimulating hormone-stimulated paracrine mechanism. Endocrinology (1993) 133(4):1532–8.10.1210/endo.133.4.8404591
    1. Thuesen L, Loft A, Egeberg A, Smitz J, Petersen JH, Andersen AN. A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization. Hum Reprod (2012) 27(10):3074–84.10.1093/humrep/des256
    1. Ezcurra D, Humaidan P. A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology. Reprod Biol Endocrinol (2014) 12:95.10.1186/1477-7827-12-95
    1. Devroey P, Boostanfar R, Koper N, Mannaerts B, Ijzerman-Boon P, Fauser BC, et al. A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Hum Reprod (2009) 24(12):3063–72.10.1093/humrep/dep291
    1. Miller KF, Behnke EJ, Arciaga RL, Goldberg JM, Chin NW, Awadalla SG. The significance of elevated progesterone at the time of administration of human chorionic gonadotropin may be related to luteal support. J Assist Reprod Genet (1996) 13(9):698–701.10.1007/BF02066420
    1. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S, et al. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. Fertil Steril (2011) 96(2):344–8.10.1016/j.fertnstert.2011.02.059
    1. Cruz M, Requena A, Guillen A, Cerrillo M, García-Velasco J. High progesterone levels in high ovarian response do not affect clinical outcomes. Fertil Steril (2013) 100(3):S109.10.1016/j.fertnstert.2013.07.1674
    1. Khalaf Y, El-Toukhy T, Coomarasamy A, Kamal A, Bolton V, Braude P. Selective single blastocyst transfer reduces the multiple pregnancy rate and increases pregnancy rates: a pre-and post-intervention study. BJOG (2008) 115(3):385–90.10.1111/j.1471-0528.2007.01584.x
    1. Shufaro Y, Sapir O, Oron G, Haroush AB, Garor R, Pinkas H, et al. Progesterone-to-follicle index is better correlated with in vitro fertilization cycle outcome than blood progesterone level. Fertil Steril (2015) 103(3):669–74.e3.10.1016/j.fertnstert.2014.11.026
    1. Lai TH, Lee FK, Lin TK, Horng SG, Chen SC, Chen YH, et al. An increased serum progesterone-to-estradiol ratio on the day of human chorionic gonadotropin administration does not have a negative impact on clinical pregnancy rate in women with normal ovarian reserve treated with a long gonadotropin releasing hormone agonist protocol. Fertil Steril (2009) 92(2):508–14.10.1016/j.fertnstert.2008.06.036
    1. Stanczyk FZ, Cho MM, Endres DB, Morrison JL, Patel S, Paulson RJ, et al. Limitations of direct estradiol and testosterone immunoassay kits. Steroids (2003) 68(14):1173–8.10.1016/j.steroids.2003.08.012
    1. Patton PE, Lim JY, Hickok LR, Kettel LM, Larson JM, Pau KY. Precision of progesterone measurements with the use of automated immunoassay analyzers and the impact on clinical decisions for in vitro fertilization. Fertil Steril (2014) 101(6):1629–36.10.1016/j.fertnstert.2014.02.037
    1. Taieb J, Benattar C, Birr AS, Lindenbaum A. Limitations of steroid determination by direct immunoassays. Clin Chem (2002) 48(3):583–5.
    1. Aflatounian A, Oskoueian H, Ahmadi S. Can fresh embryo transfers be replaced by cryopreserved-thawed embryo transfers in assisted reproductive cycles? A randomized controlled trial. J Assisted Reprod Genet (2009) 27(7):357–63.10.1007/s10815-010-9412-9
    1. Kalra SK, Ratcliffe SJ, Milman L, Gracia CR, Coutifaris C, Barnhart KT, et al. Perinatal morbidity after in vitro fertilization is lower with frozen embryo transfer. Fertil Steril (2011) 95(2):548–53.10.1016/j.fertnstert.2010.05.049
    1. Li R, Qiao J, Wang L, Zhen X, Lu Y. Serum progesterone concentration on day of HCG administration and IVF outcome. Reprod Biomed Online (2008) 16(5):627–31.10.1016/S1472-6483(10)60475-0
    1. Haahr T, Roque M, Esteves SC, Humaidan P. GnRH agonist trigger and LH activity luteal phase support versus hCG trigger and conventional luteal phase support in fresh embryo transfer IVF/ICSI cycles – a systematic PRISMA review and meta-analysis. Front Endocrinol (2017) 8:116.10.3389/fendo.2017.00116
    1. Pinborg A, Wennerholm U-B, Romundstad L, Loft A, Aittomaki K, Söderström-Anttila V, et al. Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis. Hum Reprod Update (2012) 19(2):87–104.10.1093/humupd/dms044
    1. Pinborg A, Henningsen A, Loft A, Malchau S, Forman J, Andersen AN, et al. Large baby syndrome in singletons born after frozen embryo transfer (FET): is it due to maternal factors or the cryotechnique? Hum Reprod (2014) 29(3):618–27.10.1093/humrep/det440
    1. Wennerholm U-B, Henningsen A-KA, Romundstad LB, Bergh C, Pinborg A, Skjaerven R, et al. Perinatal outcomes of children born after frozen-thawed embryo transfer: a Nordic cohort study from the CoNARTaS group. Hum Reprod (2013) 28(9):2545–53.10.1093/humrep/det272
    1. Ishihara O, Araki R, Kuwahara A, Itakura A, Saito H, Adamson GD, et al. Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single-embryo transfer cycles from 2008 to 2010 in Japan. Fertil Steril (2014) 101(1):128–33.10.1016/j.fertnstert.2013.09.025
    1. Kaser DJ, Melamed A, Bormann CL, Myers DE, Missmer SA, Walsh BW, et al. Cryopreserved embryo transfer is an independent risk factor for placenta accreta. Fertil Steril (2015) 103(5):1176–84.e2.10.1016/j.fertnstert.2015.01.021
    1. Sazonova A, Källen K, Thurin-Kjellberg A, Wennerholm U-B, Bergh C. Obstetric outcome in singletons after in vitro fertilization with cryopreserved/thawed embryos. Hum Reprod (2012) 27(5):1343–50.10.1093/humrep/des036
    1. Hart R, Norman RJ. The longer-term health outcomes for children born as a result of IVF treatment: part I – general health outcomes. Hum Reprod Update (2013) 19(3):232–43.10.1093/humupd/dmt002
    1. Meister TA, Rexhaj E, Rimoldi SF, Scherrer U, Sartori C. Effects of perinatal, late foetal, and early embryonic insults on the cardiovascular phenotype in experimental animal models and humans. Vasa (2016) 45(6):439–49.10.1024/0301-1526/a000573

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel